6ix — Find Your Next Investment

Discover investor relations events, company profiles, and investment opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Original text

Rate this translation

Your feedback will be used to help improve Google Translate

Latest Press Releases

Time	Headline
39m ago	e.l.f. Cosmetics Fuels Katherine Legge's Return to the Indianapolis 500 with eyes.lips.fuel. Takeover
1h ago	Investor Update Webcast March 2026 Quarter
1h ago	Citi Singapore receives dual award recognition from FinanceAsia and Forbes
3h ago	Eyebright Medical Releases Its 2025 Annual Report and Sustainability Report
3h ago	The Trade Desk Powers Open Internet Growth with DramaBox Short Drama Partnership

About

Organon & Co (NYSE:OGN) — investor relations, events, news, and company updates on 6ix.

Latest News

Sun Pharma signs Definitive Agreement to Acquire Organon

Organon To Report First Quarter 2026 Results and Host Conference Call on May 7, 2026

Organon’s VTAMA® (tapinarof) cream, 1%, Granted Strong Recommendation in the 2026 American Academy of Dermatology Guidelines for Pediatric Atopic Dermatitis

Organon accelerates Women's Health progress across Asia Pacific with 2026 Her Health Grants

Organon Debuts New Analysis of VTAMA® (tapinarof) cream, 1%, Phase 3 Pooled Data Demonstrating Early and Consistent Skin Clearance and Itch Improvement in Atopic Dermatitis Patients Down to 2 Years of Age

Financials

Revenue

$6.22 B

Market Cap

$1.66 B

P/E Ratio

8.83

EPS

0.72

Dividend Yield

5.54%

Community Chat

Ask AI